Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Neuropathol Appl Neurobiol. 2008 Nov 12;35(4):353–366. doi: 10.1111/j.1365-2990.2008.01001.x

TABLE 2.

Summary of the age of MB and PA cases with expression of ERBB4 JM-c or JM-d variants

Tumor type Group of cases* Median age at operation (yrs) Range of age at operation (yrs) No. of cases No. of cases expressing JM-c No. of cases expressing JM-d
MB Children 7 0.6 - 15 23 6 (26%) 15 (65%)
Adults 22 18 - 41 8 5 (63%) 5 (63%)
PA Children 6 0.5 - 14 26 11 (42%) 0
Adults 24 17 - 33 9 6 (67%) 0
*

A cut-off age of 15 years was used to divide the cases into childhood and adult groups because this age is used by the American Cancer Society (www.cancer.org) and the United Kingdom Office for National Statistics (www.statistics.gov.uk) to define childhood cancer incidence.

HHS Vulnerability Disclosure